drugset / Trial / NCT00089804
Study of LJP 394 in Lupus Patients With History of Renal Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of this study is to determine whether abetimus sodium is more effective than placebo in delaying time to renal flare in SLE patients with a history of renal disease.
Timeline
- Start
- 2004-10
- Primary completion
- 2009-02
- Completion
- 2009-02
Outcome
Outcome not reported
Stopped: “Interim efficacy analysis indicated it would be futile to continue study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abetimus | Unknown | 300 mg | Intravenous |
| Comparator | Abetimus | Unknown | 900 mg | Intravenous |